Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 100, Issue 3, Pages 559-568
Publisher
Wiley
Online
2016-03-09
DOI
10.1189/jlb.3a0514-261rr
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of Type 1 diabetes in NOD mice
- (2014) Palash Bhattacharya et al. CLINICAL IMMUNOLOGY
- Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model
- (2014) Chao-Lin Kuo et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Identification of a Broad-Spectrum Antiviral Small Molecule against Severe Acute Respiratory Syndrome Coronavirus and Ebola, Hendra, and Nipah Viruses by Using a Novel High-Throughput Screening Assay
- (2014) H. A. Elshabrawy et al. JOURNAL OF VIROLOGY
- TREG-cell therapies for autoimmune rheumatic diseases
- (2014) Makoto Miyara et al. Nature Reviews Rheumatology
- EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
- (2014) Eun-Ji Yang et al. PLoS One
- CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner
- (2013) Behdad Afzali et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets
- (2013) Jae-Kyeong Byun et al. IMMUNOLOGY LETTERS
- The Novel Role of IL-7 Ligation to IL-7 Receptor in Myeloid Cells of Rheumatoid Arthritis and Collagen-Induced Arthritis
- (2013) Z. Chen et al. JOURNAL OF IMMUNOLOGY
- Green tea polyphenol, (−)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling
- (2013) Tripti Singh et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells
- (2012) Ji Hyeon Ju et al. ARTHRITIS AND RHEUMATISM
- A Novel Combination of Methotrexate and Epigallocatechin Attenuates the Overexpression of Pro-inflammatory Cartilage Cytokines and Modulates Antioxidant Status in Adjuvant Arthritic Rats
- (2012) Souvik Roy et al. INFLAMMATION
- EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
- (2012) Su-Ni Tang et al. PLoS One
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes
- (2012) Sung Gu Han et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Deficiency of Nrf2 Accelerates the Effector Phase of Arthritis and Aggravates Joint Disease
- (2011) Nuria Maicas et al. ANTIOXIDANTS & REDOX SIGNALING
- Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation
- (2011) Pei-Yi Tsai et al. FREE RADICAL BIOLOGY AND MEDICINE
- (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 бvia Stat3 in gastric cancer
- (2011) Bao-He Zhu WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmacologic Inhibition of MEK–ERK Signaling Enhances Th17 Differentiation
- (2010) Andy Hee-Meng Tan et al. JOURNAL OF IMMUNOLOGY
- Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor α-induced apoptosis
- (2009) Salahuddin Ahmed et al. ARTHRITIS AND RHEUMATISM
- Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor- B Signal
- (2009) J.-H. Lee et al. MOLECULAR PHARMACOLOGY
- (−)‐Epigallocatechin‐3‐gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice
- (2008) Akio Morinobu et al. ARTHRITIS AND RHEUMATISM
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events
- (2008) Hong Ro Kim et al. JOURNAL OF NUTRITION
- Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
- (2008) S. Ahmed et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigallocatechin-3-gallate suppresses TNF-α -induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts
- (2008) Hee-Jin Yun et al. RHEUMATOLOGY INTERNATIONAL
- TH-17 cells in rheumatoid arthritis
- (2008) Shiva Shahrara et al. ARTHRITIS RESEARCH & THERAPY
- Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG
- (2007) Hye-Kyung Na et al. FOOD AND CHEMICAL TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started